The  International Academy of Compounding Pharmacists (IACP)  on behalf  of our more than 4,000 compounding pharmacists and the patients and providers they serve, is sharing the information from the Centers for Disease Control and Prevention (CDC) announcing that new drugs are being proposed for the NIOSH List of Antineoplastic and Other Hazardous drugs in Healthcare Settings, 2018.  Any changes to the NIOSH list will effect compounding pharmacies and how USP <800> is implemented in their pharmacies due to the items present on the list.

IACP members are encouraged to comment. 

The list is open for comment until Monday, April 16, 2018.  

The proposed list and details on how to comment can be found HERE .

The link to the Federal Register NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 can be found HERE.